Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: Relevance to AD

NeuroToxicology

Volumn 44, Issue , 2014, Pages 114-120

  Bihaqi, Syed Waseem ^a   Bahmani, Azadeh ^a   Adem, Abdu ^b   Zawia, Nasser H ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Aging; CDK5; Hyperphosphorylation; Lead; Tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; LEAD; MESSENGER RNA; PROTEIN P25; PROTEIN P35; PROTEIN SERINE THREONINE KINASE; TAU PROTEIN; PHOSPHOSERINE; PHOSPHOTHREONINE; CDK5R1 PROTEIN, MOUSE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOTRANSFERASE;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; LIFESPAN; MALE; MOUSE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ADULT; ENVIRONMENTAL FACTOR; INFANT; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PROTEIN DETERMINATION; TAU GENE; UPREGULATION; WESTERN BLOTTING; AGE; ANIMAL; C57BL MOUSE; METABOLISM; PHOSPHORYLATION;

MUS;

AGE FACTORS; ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; LEAD; MALE; MICE; MICE, INBRED C57BL; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; RNA, MESSENGER; TAU PROTEINS;

EID: 84903746263     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.06.008     Document Type: Article

References (33)

1. Alonso A.C., Grundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996, 2:783-787.
2. Bihaqi S.W., Huang H., Wu J., Zawia N.H. Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease. J Alzheimers Dis 2011, 27:819-833.
3. Bihaqi S.W., Bahmani A., Subaiea G.M., Zawia N.H. Infantile exposure to lead and late-age cognitive decline: relevance to AD. Alzheimers Dement 2014, 2:187-195.
4. Bihaqi S.W., Zawia N.H. Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology 2013, 39C:95-101.
5. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
6. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 1998, 143:777-794.
7. Gendron T.F., Petrucelli L. The role of tau in neurodegeneration. Mol Neurodegener 2009, 4:13.
8. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995, 65:732-738.
9. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003, 60:1119-1122.
10. Imahori K., Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J Biochem 1997, 121:179-188.
11. Iqbal K., Liu F., Gong C.X., Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 2010, 7:656-664.
12. Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., et al. Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci 2004, 24:2304-2312.
13. Liddell M.B., Lovestone S., Owen M.J. Genetic risk of Alzheimer's disease: advising relatives. Br J Psychiatry 2001, 178:7-11.
14. Liu F., Li B., Tung E.J., Grundke-Iqbal I., Iqbal K., Gong C.X. Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur J Neurosci 2007, 26:3429-3436.
15. Mandelkow E.M., Mandelkow E. Tau protein and Alzheimer's disease. Neurobiol Aging 1994, 15(Suppl. 2):S85-S86.
16. Mazumdar M., Bellinger D.C., Gregas M., Abanilla K., Bacic J., Needleman H.L. Low-level environmental lead exposure in childhood and adult intellectual function: a follow-up study. Environ Health 2011, 10:24.
17. Muldoon S.B., Cauley J.A., Kuller L.H., Morrow L., Needleman H.L., Scott J., et al. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 1996, 15:62-72.
18. Mushak P., Davis J.M., Crocetti A.F., Grant L.D. Prenatal and postnatal effects of low-level lead exposure: integrated summary of a report to the U.S. Congress on childhood lead poisoning. Environ Res 1989, 50:11-36.
19. Nordberg M., Winblad B., Fratiglioni L., Basun H. Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population-based study. Am J Ind Med 2000, 38:290-294.
20. Payton M., Riggs K.M., Spiro A., Weiss S.T., Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 1998, 20:19-27.
21. Peters J.L., Weisskopf M.G., Spiro A., Schwartz J., Sparrow D., Nie H., et al. Interaction of stress, lead burden, and age on cognition in older men: the VA Normative Aging Study. Environ Health Perspect 2010, 118:505-510.
22. Rahman A., Brew B.J., Guillemin G.J. Lead dysregulates serine/threonine protein phosphatases in human neurons. Neurochem Res 2011, 36:195-204.
23. Salehi A., Delcroix J.D., Mobley W.C. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci 2003, 26:73-80.
24. Selkoe D.J. Amyloid protein and Alzheimer's disease. Sci Am 1991, 265. 68-71, 74-66, 78.
25. Takahashi M., Iseki E., Kosaka K. Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains. J Neurol Sci 2000, 172:63-69.
26. Tanzi R.E., Bertram L. Alzheimer's disease: the latest suspect. Nature 2008, 454:706-708.
27. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S.T., Takei K., et al. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 2002, 22:2590-2597.
28. Tong S., von Schirnding Y.E., Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. Bull World Health Organ 2000, 78:1068-1077.
29. Weisskopf M.G., Proctor S.P., Wright R.O., Schwartz J., Spiro A., Sparrow D., et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 2007, 18:59-66.
30. Weisskopf M.G., Wright R.O., Schwartz J., Spiro A., Sparrow D., Aro A., et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol 2004, 160:1184-1193.
31. Weuve J., Korrick S.A., Weisskopf M.G., Ryan L.M., Schwartz J., Nie H., et al. Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect 2009, 117:574-580.
32. Wright R.O., Tsaih S.W., Schwartz J., Spiro A., McDonald K., Weiss S.T., et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003, 14:713-718.
33. Zawia N.H., Basha M.R. Environmental risk factors and the developmental basis for Alzheimer's disease. Rev Neurosci 2005, 16:325-337.